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ABSTRACT
Objective: Identification of primary care factors
associated with hospital admissions for adverse drug
reactions (ADRs).
Design and setting: Cross-sectional analysis of
2010–2012 data from all National Health Service
hospitals and 7664 of 8358 general practices in
England.
Method: We identified all hospital episodes with an
International Classification of Diseases (ICD) 10 code
indicative of an ADR, in the 2010–2012 English Hospital
Episode Statistics (HES) admissions database. These
episodes were linked to contemporary data describing
the associated general practice, including general
practitioner (GP) and patient demographics, an estimate
of overall patient population morbidity, measures of
primary care supply, and Quality and Outcomes
Framework (QOF) quality scores. Poisson regression
models were used to examine associations between
primary care factors and ADR-related episode rates.
Results: 212 813 ADR-related HES episodes were
identified. Rates of episodes were relatively high
among the very young, older and female subgroups. In
fully adjusted models, the following primary care
factors were associated with increased likelihood of
episode: higher deprivation scores (population
attributable fraction (PAF)=0.084, 95% CI 0.067 to
0.100) and relatively poor glycated haemoglobin
(HbA1c) control among patients with diabetes
(PAF=0.372; 0.218 to 0.496). The following were
associated with reduced episode likelihood: lower GP
supply (PAF=−0.016; −0.026 to −0.005), a lower
proportion of GPs with UK qualifications (PAF=−0.035;
−0.058 to −0.012), lower total QOF achievement rates
(PAF=−0.021; −0.042 to 0.000) and relatively poor
blood pressure control among patients with diabetes
(PAF=−0.144; −0.280 to −0.022).
Conclusions: Various aspects of primary care are
associated with ADR-related hospital episodes,
including achievement of particular QOF indicators.
Further investigation with individual level data would
help develop understanding of the associations
identified. Interventions in primary care could help
reduce the ADR burden. ADRs are candidates for
primary care sensitive conditions.
INTRODUCTION
Adverse drug reactions (ADRs) have been
described as the undesirable and unintended
effects of drugs further to their anticipated
therapeutic impact, at usual therapeutic
doses.1 They may be predictable or unpre-
dictable, and acceptable or not.2 Occurrence
is inﬂuenced by local practice,3 including
prescribing systems,4 drug monitoring and
associated systems,5 6 drug interactions and
polypharmacy,7 8 and individual patient
characteristics.3 They are caused by both
over-the-counter and prescription medica-
tions.9 They are a major source of iatrogenic
harm, and associated with excess morbidity
and mortality.10 A 2002 review suggested
approximately 7% of UK emergency hospital
admissions and 4 in 100 UK hospital
bed-days are associated with ADRs.11
Unadjusted numbers of ADR-related admis-
sions have been increasing since the late
1990s, with rates of increase exceeding those
for hospital admissions per se.12 13 Enhanced
reporting,14 population ageing, increasing
comorbidity and polypharmacy15 are likely to
have contributed to these upward trends.
The economic cost of these admissions and
some other aspects of ADR management was
estimated at £750 million per year in 2006.16
Strengths and limitations of this study
▪ We analysed recent data with national coverage.
▪ Practice-specific data were available for all
predictors.
▪ The analysis was cross-sectional and at practice-
level. We can therefore neither infer that the
observed associations are causally linked, nor
that they persist at the individual level.
▪ We were unable to directly adjust for prescribing
burden.
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A recent meta-analysis17 concluded that approximately
half of the ADRs identiﬁed in secondary care are pre-
ventable. However, identifying interventions with consist-
ent positive impact on prescribing errors or ADRs has
been difﬁcult.18–20 Studies linking both prescribing
habits and hospital admissions for particular conditions
with primary care provision and performance, neverthe-
less, indicate that modiﬁable aspects of primary care
inﬂuence ADR and hospital admission rates. For
example, two recent analyses of primary care data
support a negative correlation between prescribing
errors, and both, practice list size and designation, as a
training versus non-training practice.3 21 General practi-
tioner (GP) age, sex, handedness of practice and list size
have also been linked to ADR reporting (potentially a
proxy for pharmacovigilance more generally),22 and list
size, GP supply and country of qualiﬁcation with admis-
sion rates, for several other particular conditions.23–27
Quality and Outcomes Framework (QOF) performance,
on both clinical and service access indicators, has been
linked to admission rates for various conditions.23–27
To further assess the extent to which ADRs might be
inﬂuenced by primary care, we have here considered, at
practice level, associations between ADR-related admis-
sions and practice demographics, patient factors, mea-
sures of primary care supply and performance
indicators. We hypothesised that lower ADR admission
rates would be associated with higher resourcing and
performance measures.
METHODS
Ethics statement
This was a secondary use of administrative data. The
only patient-level data used were Hospital Episode
Statistics (HES) data provided by the Health and Social
Care Information Centre (HSCIC). The remainder of
the data were publicly available practice-level data from
the HSCIC (http://www.hscic.gov.uk/home). This is
also the case with other published UK analyses that have
used HES data.
Study design, data sources and variables
We performed a cross-sectional analysis of 2010–2012
hospital and primary care data from England.
Outcome data
The admissions data used to generate our outcome vari-
able were extracted from the 2010 to 2012 English HES
Admitted Patient Care data. All episodes of in-hospital
care delivered in National Health Service (NHS) hospi-
tals or funded by the NHS are included in this data set.
This covers the vast majority of emergency admissions.
Accident and emergency attendances without subse-
quent admission are not included. Each database entry
(‘episode’) corresponds to an uninterrupted period of
care under a particular hospital consultant. A single
inpatient admission in one hospital trust (a HES ‘spell’)
can therefore include more than one episode. Duplicate
entries (0.026% of total) were excluded. National audit
of HES admissions data has shown that 89% of primary
diagnoses are valid.28
We deﬁned ADR-associated episodes as those with an
International Classiﬁcation of Diseases (ICD) 10 diagno-
sis term containing the terms, ‘drug-induced’, ‘due to
[drug]’, ‘induced by [drug]’, ‘adverse effect of correct
drug’, or ‘adverse event of drug’. Those with diagnoses
of ‘malignant neuroleptic syndrome’, ‘ototoxic hearing
loss’, ‘toxic liver disease’, ‘toxic epidermal necrolysis’,
‘drug phototoxic response’, ‘drug photoallergic
response’, ‘post-immunisation arthropathy’, ‘complica-
tions following infusion, transfusion and therapeutic
injection’ and ‘infection following immunisation’, were
also included, as were those with a diagnosis ﬁeld con-
taining an ‘external cause’ code between Y40 and Y59,
which indicate that a drug is the expected cause of a
particular diagnosis. Drug-associated poisoning was
excluded. An exhaustive list of eligible ICD-10 codes is
available as online supplementary ﬁle S1. We used the
general practice linked to each of the included HES epi-
sodes to calculate numbers of ADR-associated episodes
per practice.
Predictor variables: practice demographics and
performance measures
Various practice demographic and performance mea-
sures were used as predictor variables. Data were
obtained from the HSCIC. The following predictors
were generated from the 2012 General and Personal
Medical Services Data:29
▸ Continuous
1. Practice list size
2. GP supply: number of full-time equivalent (FTE)
GPs/1000 patients
3. Per cent of GPs ≥50 years
4. Per cent of female GPs
5. Per cent of GPs with non-UK primary medical
qualiﬁcations
▸ Binary
6. Single-handed/multihanded practice.
The practitioner-related data accounted for all GP pro-
viders, salaried/other GPs, GP retainers and GP regis-
trars. Overall 2011–2012 practice QOF performance
(per cent of maximum score of 1000 points achieved),
and the following 2011–2012 QOF clinical and medica-
tion management indicators,30 were identiﬁed as add-
itional predictors:
1. Clinical indicators (as markers for overall clinical
quality of care)
A. CHD06: The percentage of patients with coronary
heart disease in whom the last blood pressure
reading (measured in the preceding 15 months) is
150/90 or less
B. CHD08: The percentage of patients with coronary
heart disease whose last measured total cholesterol
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(measured in the preceding 15 months) is 5 mmol/L
or less;
C. STROKE06: The percentage of patients with a
history of transient ischaemic attack (TIA) or stroke
in whom the last blood pressure reading (measured
in the preceding 15 months) is 150/90 mm Hg or
less;
D. STROKE08: The percentage of patients with TIA or
stroke whose last measured total cholesterol (mea-
sured in the preceding 15 months) is 5 mmol/L or
less;
E. DM17: The percentage of patients with diabetes
whose last measured total cholesterol within the pre-
ceding 15 months is 5 mmol/L or less;
F. DM26: The percentage of patients with diabetes in
whom the last International Federation of Clinical
Chemistry (IFCC)-glycated haemoglobin (HbA1c)
is 59 mmol/mol (equivalent to HbA1c of 7.5% in
Diabetes Control and Complications Trial units)
or less (or equivalent test/reference range
depending on local laboratory) in the preceding
15 months;
G. DM30: The percentage of patients with diabetes in
whom the last blood pressure is 150/90 or less;
H. BP05: The percentage of patients with hypertension
in whom the last blood pressure (measured in the
preceding 9 months) is 150/90 mm Hg or less.
2. Medication management (both binary indicators)
A. MEDICINES12: A medication review is recorded in
the notes in the preceding 15 months for all patients
being prescribed repeat medicines, standard 80%;
B. RECORDS09: For repeat medicines, an indication
for the drug can be identiﬁed in the records (for
drugs added to repeat prescriptions with effect from
2 April 2004), minimum standard 80%.
These particular clinical indicators were selected as
they are important indicators related to common con-
ditions relevant to all practices. They apply dispropor-
tionately to older age groups and those with
multimorbidity (among whom the targets will be more
challenging to meet), and reﬂect the need for long-
term monitoring, which can also be difﬁcult to
achieve. The 2010–2011 QOF patient experience indi-
cator data were used, as these indicators were dropped
in 2011–2012:
1. PE07: Patient experience of access (1). The percent-
age of patients who, in the GP Patient Survey, indi-
cate that they were able to obtain a consultation with
a GP within two working days. (NB: The GP Patient
Survey is a national survey run by an independent
survey agency for the NHS. 1.4 million adult patients
registered with a GP in England are sampled 4×/year.
Almost 2 million responses were received in 2010–
2011; response rate=36%.)31
2. PE08: Patient experience of access (2). The percent-
age of patients who, in the appropriate national
survey, indicate that they were able to book an
appointment with a GP more than two days ahead.
Predictor variables: patient population sociodemographic
and comorbidity data
Covariates included descriptors of practice populations.
The age and gender distributions of each practice popu-
lation (at 2011), and their Index of Multiple Deprivation
(IMD) scores (from 2010), were obtained from the
HSCIC Indicator Portal.32 The following variables were
produced with these data:
1. Age group (categorical variable using Ofﬁce for
National Statistics (ONS) age-bands);
2. Sex (male/female binary variable);
3. IMD score (continuous variable).
A summary practice population ethnicity variable was
produced using 2011 ONS Census data.33 The ethnicity
categories were collapsed into a ‘per cent white’ variable
(per cent belonging to any of the English/Welsh/
Scottish/Northern Irish/British, Irish, Gypsy or Irish
Traveller or Other White groups).
As disease burden is associated with rates of admis-
sions, prescribing burden and ADRs,34 35 a practice mor-
bidity variable was produced by totalling the numbers of
practice QOF disease registrations (2011–2012) for cor-
onary heart disease, heart failure, stroke/TIA, hyperten-
sion, atrial ﬁbrillation, diabetes mellitus, chronic
obstructive pulmonary disease, asthma, epilepsy, hypo-
thyroidism, cancer, palliative care, schizophrenia, bipolar
disorder, other psychoses, depression and dementia, and
expressing this as a proportion of list size. Comparison
with the Charlson Index has indicated that QOF registra-
tion data can reasonably estimate morbidity.36
Exclusions
Practices for which a patient count was not available
(n=153), with an incomplete set of predictors (n=538)
and/or with a list size <500 (n=3), were excluded from
analysis.
Statistical analysis
For each combination of practice, sex and age group, we
computed a count of total ADR-related HES episodes
for 2010–2012, and ﬁtted Poisson general estimating
equation (GEE) regression models to these data, using
Huber variances clustered by practice, with an exposure
variable equal to the number of patients in that practice
with that gender and age group. For estimating crude
rates by gender and age group, we used GEEs with zero
correlation. For estimating effects of practice-level pre-
dictors, we used GEEs with exchangeable correlation.
The parameters of the practice-effects models were a
base ADR rate for each combination of gender and age
group, and rate ratios corresponding to practice-speciﬁc
risk factors, which were constant within each practice.
For each risk factor, we ﬁtted an unadjusted model, the
parameters of which were the base ADR rates and risk
ratios for that factor, using binary indicators for binary
factors and the quadratic reference-spline method for
continuous factors.37 We then ﬁtted an adjusted model,
containing the base rates and rate ratios for all the risk
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factors. For each factor (continuous or binary), we esti-
mated the adjusted and unadjusted population attribut-
able fraction (PAF), comparing ADR rates between the
real-world scenario and a hypothetical scenario where
that factor was at the base level for all participants.38
Table 1 displays the baseline and other reference points
for all predictors. The reference-spline models used
allow the real world to be compared with a hypothetical
scenario, in which all practices had the baseline level of
a continuous covariate. The PAF is then the proportion
of ADRs attributable to living in the real world, instead
of in the hypothetical scenario. For instance, in the
case of GP supply (FTE/1000 patients), the real world is
compared to a hypothetical scenario, in which each
practice had 7.5 FTEs per 1000 patients. Analyses were
carried out using V.13.1 of Stata statistical software.39
RESULTS
Summary statistics
After removal of duplicates, 212 813 ADR-related HES
episodes were identiﬁed. Following practice exclusions
(as above), 7664 (91.7% of 8358) practices remained,
with 53 422 119 registered patients. These included prac-
tices that were associated with 201 246 (94.6%) of the
identiﬁed HES episodes; 72.1% of these episodes
(n=145 077) were discrete admissions to an NHS Trust
(ie, did not occur within the same HES spell). Table 2
displays the number of episodes containing ADR-related
ICD-10 codes, by ICD-10 chapter. Most episodes were
identiﬁed by an ‘external cause’ code, as anticipated in
view of the limited number of primary diagnosis codes
that attribute a diagnosis to a drug. It is likely that some
episodes had both, diagnosis and external cause codes,
indicative of an ADR, as the information each provides
(disease attributed to drug, and drug considered respon-
sible, respectively), is different. It is also possible that
some individuals received more than one ADR diagnosis.
Practice admission and demographic characteristics,
the nature of their patient populations and their QOF
performance outcomes, are summarised in table 3.
Clustering around high levels of achievement was appar-
ent for many of the QOF outcomes.
Table 4 displays ADR-related episode rates by patient
age and sex. Relatively high rates were apparent in the
very young and older age groups. Post 0–4 years (for
whom rates=0.76/1000 person-years, 95% CI 0.70 to
0.81), rates increased with age, from 0.37 (0.34 to
0.40) per 1000 person-years among the 5–14 years age
group, to 12.3 (11.9 to 12.6) per 1000 person-years
among the ≥85 years age group. Rates were also
higher among females compared with males: 2.10
(2.06 to 2.14) vs 1.66 (1.63 to 1.70) per 1000 person-
years, respectively.
ADR episodes and practice characteristics
The regression analysis outcomes are reported as
unadjusted and adjusted PAFs (table 5). These describe,
for each predictor, the proportional difference in
ADR-related episode rates associated with the difference
between the reference scenario for that variable (base-
line in table 1) and the sample scenario. The unadjusted
and adjusted incidence rate ratios associated with each
of the reference points for each factor (as per table 1)
are reported in online supplementary ﬁle S2. In fully
adjusted models, the following factors were associated
with increased likelihood of ADR-related episode:
higher deprivation scores, higher GP supply, a higher
proportion of GPs with UK qualiﬁcations, higher total
QOF achievement rates, lower performance on QOF
indicator DM26 (ie, relatively poor HbA1c control
among patients with diabetes) and higher performance
on indicator DM30 (ie, relatively good blood pressure
control among patients with diabetes). Examination of
the rate ratios corresponding to HES episode rates in
the scenarios where either 50% or 100%—vs 0%—of
GPs held non-UK qualiﬁcations, however, suggested a
non-linear association between ADR-related episodes
and country of qualiﬁcation (adjusted rate ratio (ARR)
for 50% vs 0%=0.92 (95% CI 0.88 to 0.97; p=0.0025),
whereas ARR for 100% vs 0%=0.97 (0.91 to 1.04;
Table 1 Reference points for predictors
Predictor
Baseline
reference
point
Additional
reference
points
Patient population
IMD 10 10, 25, 40
Ethnicity (% white) 100 50, 90, 100
Practice morbidity index
(registrations/1000 patients)
0 0, 500, 750
Practice demographics
GP supply (FTE/1000
patients)
7.5 4.5, 6, 7.5
Handedness of practice* 0 0, 1
GPs >50 years (%) 0 0, 50, 100
GPs with non-UK
qualifications (%)
0 0, 50, 100
Female GPs (%) 0 0, 50, 100
QOF indicator achievement (%)
Total QOF points 100 90, 95, 100
PE07 100 60, 80, 100
PE08 100 60, 80, 100
CHD06 100 80, 90, 100
CHD08 100 60, 80, 100
STROKE06 100 80, 90, 100
STROKE08 100 60, 80, 100
DM17 100 60, 80, 100
DM26 100 40, 70, 100
DM30 100 80, 90, 100
BP05 100 60, 80, 100
MED12 100 0, 100
RECORD09 100 0, 100
*Multihanded, 0, single-handed, 1.
FTE, full-time equivalent; GP, general practitioner; IMD, Index of
Multiple Deprivation; QOF, Quality and Outcomes Framework.
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p=0.42); online supplementary ﬁle S2). Additionally, the
rate ratio corresponding to the episode rates in the scen-
ario where binary QOF indicator RECORD09 was univer-
sally not achieved, compared with universally achieved,
was indicative of a bottom-end negative association
between indicator achievement (drug indications noted
in patient records) and episode rates (ARR for indicator
non-achievement vs achievement=1.08 (1.00 to 1.16);
p=0.046).
DISCUSSION
Summary of results
We aimed to investigate associations between
ADR-related HES episodes and various aspects of
primary care, including performance, in an observa-
tional study of 2010–2012 data. In our sample, the
number of ADR-related episodes, and their distribution
by population age and sex, was consistent with previous
studies.12 Higher deprivation scores, higher GP supply, a
Table 2 Distribution of identified ADR-related episodes by ICD-10 chapter
ICD-10 chapter/subdivision (title)
Number of
episodes identified
Percentage of
episodes identified
ADR-related episodes identified by primary diagnosis code
III (Diseases of the blood and blood-forming organs and certain disorders
involving the immune mechanism)
1047 0.5
IV (Endocrine, nutritional and metabolic diseases) 5899 2.9
V (Mental and behavioural disorders) 156 0.1
VI (Diseases of the nervous system) 7476 3.7
VII (Diseases of the eye and adnexa)
VIII (Diseases of the ear and mastoid process)
IX (Diseases of the circulatory system) 10 834 5.4
X (Diseases of the respiratory system) 790 0.4
XI (Diseases of the digestive system) 704 0.3
XII (Diseases of the skin and subcutaneous tissue) 9818 4.9
XIII (Diseases of the musculoskeletal system and connective tissue) 2661 1.3
XIV (Diseases of the genitourinary system) 2285 1.1
XIX (Injury, poisoning and certain other consequences of external causes) 11 390 5.7
Total identified episodes with ADR-related primary diagnosis codes 53 226 26.4
ADR-related episodes identified by external cause code (under Chapter XX: External causes of morbidity and mortality,
section Y40-Y59: Drugs, medicaments and biological substances causing adverse effects in therapeutic use)
Y40: Systemic antibiotics 17 231 8.6
Y41: Other systemic anti-infectives and antiparasitics 3999 2.0
Y42: Hormones and their synthetic substitutes and antagonists not elsewhere
classified
16 724 8.3
Y43: Primarily systemic agents 44 703 22.2
Y44: Agents primarily affecting blood constituents 9232 4.6
Y45: Analgesics, antipyretics and anti-inflammatory drugs 23 753 11.8
Y46: Antiepileptics and antiparkinsonism drugs 3910 1.9
Y47: Sedatives, hypnotics and antianxiety drugs 1682 0.8
Y48: Anaesthetics and therapeutic gases 1799 0.9
Y49: Psychotropic drugs not elsewhere classified 6794 3.4
Y50: Central nervous system stimulants not elsewhere classified 201 0.1
Y51: Drugs primarily affecting the autonomic nervous system 8551 4.2
Y52: Agents primarily affecting the cardiovascular system 21 019 10.4
Y53: Agents primarily affecting the gastrointestinal system 2546 1.3
Y54: Agents primarily affecting water-balance and mineral and uric acid
metabolism
15 535 7.7
Y55: Agents primarily acting on smooth and skeletal muscles and the
respiratory system
1412 0.7
Y56: Topical agents primarily affecting skin and mucous membrane and
ophthalmological, otorhinolaryngological and dental drugs
2788 1.4
Y57: Other and unspecified drugs and medicaments 8548 4.2
Y58: Bacterial vaccines 492 0.2
Y59: Other and unspecified vaccines and biological substances 921 0.5
Total identified episodes with ADR-related external cause code 184 442 91.7
Total ADR-related episodes 201 246
The number of identified Hospital Episode Statistics episodes with ADR-related ICD-10 codes, by ICD-10 chapter and subdivisions of Chapter
XX (External causes of morbidity and mortality).
ADR, adverse drug reaction; ICD, International Classification of Diseases.
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higher proportion of GPs with UK qualiﬁcations, high
total QOF achievement, relatively poor HbA1c control
among patients with diabetes, relatively good blood pres-
sure control among patients with diabetes and poten-
tially lower recording of drug indications in patient
records, were positively associated with increased likeli-
hood of ADR-related episodes.
Comparison with the existing literature
The association between ADR-related episodes and
country of medical qualiﬁcation was non-linear, and
potentially spurious in a context of multiple compari-
sons and likely residual confounding. Country of quali-
ﬁcation has previously been associated with unplanned
cancer admissions, but in that case, non-UK qualiﬁca-
tion was associated with increased likelihood of admis-
sion.27 Similar variety in direction of effect on
admission rates has been observed for GP supply.
Where positive correlations between supply and admis-
sions have been observed (as here, and previously for
stroke admissions25), this could potentially reﬂect a loss
of continuity of care due to care for individual patients
being shared by a larger number of GPs. It is also
plausible that more GPs per patient would enhance
rates of identiﬁcation and reporting of ADRs, rather
than ADR occurrence. It is difﬁcult to imagine that
more GPs would have a negative impact on ADR
episode rates per se.
The observed effect of deprivation is in keeping with
its consistent positive association with emergency admis-
sion rates—both generally, and for various speciﬁc con-
ditions, including ADRs.27 40–42 Further studies have
linked lower socioeconomic status with greater polyphar-
macy, higher prescription rates for drugs commonly
implicated in ADRs and higher drug dosage,43 44 with
dosage reportedly higher despite adjustment for
multimorbidity.
We are cautious about the apparent association
between higher total QOF achievement and ADR epi-
sodes in view of the small effect size, multiple compari-
sons and a high degree of clustering around high
achievement. High total QOF achievement has previ-
ously been associated with a reduced likelihood of
admission for both cancer and angina.26 45 This is not
necessarily out of keeping with our observation,
however, as many QOF indicators are directly or indir-
ectly associated with prescribing. That is, prescribing
burden may be part of the apparent effect of overall
Table 3 Practice characteristics
Median IQR Per cent
HES episodes associated with ADRs (total count 2010–2012) 19 7–38
Patient population characteristics
Patient age (% >65 years) 16.0 11.8–19.5
Patient sex (% female) 50.3 49.0–51.2
Patient ethnicity (% white) 92.8 76.5–97.2
Patient morbidity score (registrations/1000 patients) 500.4 424.8–568.8
IMD 21.7 13.7–32.0
Practice characteristics
Practice list size (1000s) 6.2 3.7–9.4
GP supply (FTE/1000 patients) 6.0 4.9–7.5
Handedness of practice (% single-handed) 10.2
GPs >50 years (%) 40.0 22.2–60.0
Female GPs (%) 50.0 33.3–60.0
GPs with non-UK qualifications (%) 20.0 0.0–50.0
QOF indicator achievement
Total QOF points (%) 98.6 96.8–99.4
PE07 (%) 84.4 76.8–91.1
PE08 (%) 77.8 66.5–87.5
CHD06 (%) 90.6 87.7–93.3
CHD08 (%) 80.2 75.9–84.5
STROKE06 (%) 89.2 85.5–92.3
STROKE08 (%) 77.8 72.4–82.5
DM17 (%) 81.9 77.8–85.6
DM26 (%) 70.2 65.0–75.1
DM30 (%) 90.4 87.4–93.2
BP05 (%) 80.3 76.2–84.0
MED12 (% of practices achieving target) 96.8
RECORD09 (% of practices achieving target) 93.5
Median and IQR for continuous variables, and percentage of practices single-handed, and achieving QOF indicators MED12 and
RECORD09, are displayed.
ADR, adverse drug reaction; FTE, full-time equivalent; GP, general practitioner; HES, Hospital Episode Statistics; IMD, Index of Multiple
Deprivation; QOF, Quality and Outcomes Framework.
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QOF achievement. The observed association between
the DM30 blood pressure control indicator and ADR
episodes provides an example of a target that may be
associated with increased rates of ADRs, via higher pre-
scribing rates. A recent meta-analysis suggested that rela-
tively tight blood pressure control among those with
diabetes is associated with higher risk of signiﬁcant
adverse events, although this was with control to lower
levels than we have speciﬁcally investigated here.46 It is
also possible that higher QOF achievement is reﬂective
of relatively high-quality care in general, and thus, again,
that this is associated with enhanced identiﬁcation and
reporting of ADRs, rather than ADR occurrence per se.
In contrast with blood pressure control, better HbA1c
control was observed to be negatively associated with
HES episode rates. Potentially relatively high HbA1c
reﬂects treatment resistance, and higher levels of oral
hypoglycaemic agent and insulin prescribing, which are
known risk factors for ADR-related admissions.47 Reverse
causality—whereby ADRs could impact on treatment
adherence, or the treatment options available, and
therefore QOF performance—may also be relevant.
Although we did not observe a signiﬁcant association
between either of the medication management QOF
indicators and episodes when considering PAFs, the rate
ratios calculated did suggest a small negative association
between recording of drug indications and ADR-related
episodes. As the record-related data were binary and
clustered at high levels, further study with data that
provide more information would be of interest.
Strengths and limitations
Previous studies have considered associations between
primary care factors and prescribing errors/high-risk
prescribing,3 21 but so far as we are aware, this is the ﬁrst
study to investigate associations between primary care
factors and ADR-related hospital episodes. The data
available covered the majority of the English population,
and we were able to control for important covariates.
A limitation of the analysis was its cross-sectional and
practice level nature, which means that we can infer
neither causal links between the observed associations,
nor individual level associations, and the ecological
fallacy could operate. Additional limitations include the
potential for inaccuracies and inconsistencies in the data
sets used. HES data are based on patient notes and
therefore reﬂect the quality of clinical record-keeping.
Evidence from several reports suggests ADRs are under-
estimated in HES data.12 14 48 Suggested reasons for
under-estimation include under-recognition, under-
recording and the limited scope of the relevant ICD-10
codes.14 Variation in coding practice by hospital/trust is
also possible, but as our sample size was large, this is
unlikely to be an important confounder. The data
describing GP characteristics and supply did not include
locum doctors. As the proportion of primary care deliv-
ered by locum doctors is now considerable, discrepan-
cies between the data and practice will exist. This issue
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also affects the practice handedness variable, which, in
view of the contributions made by locum doctors, is
likely to represent the management structure of the
practice as much as the number of doctors it employs.
We were constrained in looking at medical training, as
further to those describing ‘non-UK qualiﬁcation’, data
are not easily available for use.
Regarding our deﬁnition of ADR-related episodes, we
were unable to identify episodes that were unavoidable,
due to over-the-counter medications, or to prescribing
in secondary care. Moreover, we were unable to identify
appropriate high-risk prescribing (ie, instances where
the risk of ADR was known and accepted). It is not
anticipated that these cases would be systematically asso-
ciated with particular aspects of primary care in a large
data set, but they may have limited the extent to which
associations with primary care could be identiﬁed. We
were also unable to adjust for prescribing burden dir-
ectly, as we were unable to identify suitable data.
Implications for research and practice
We have previously suggested that observed associations
between primary care factors and admissions for
particular conditions support their classiﬁcation as
primary care sensitive conditions (PCSCs).23 PCSCs are
deﬁned as those conditions for which high-quality
primary care can limit disease progression, complica-
tions and the need for secondary care.49 The concept
has arisen in line with the pressures on primary care
systems to limit hospital utilisation as demand has
increased. However, there remains no widespread con-
sensus on, or empirical basis for, criteria by which to
identify PCSCs.50 ADRs have not typically been consid-
ered PCSCs,51 52 but our data indicate that they are
likely sensitive to changes in primary care practice.
Classifying ADRs as PCSCs could help encourage
engagement with the issue, and allocate resources for
investigation and implementation of strategies to reduce
incidence, at the primary care level. Speciﬁc suggestions
regarding strategies are difﬁcult to make without further
analyses to help understand some of the associations
identiﬁed.
A particular issue raised by our analysis is the possibil-
ity that QOF targets may act to tip relatively high-risk
prescribing decisions in favour of prescribing. This sug-
gestion has been made previously,53 and previous
Table 5 Associations between hospital episodes and primary care factors: population-attributable fractions
Unadjusted PAF (95% CI)* p Value Adjusted PAF (95% CI)† p Value
Patient population factors
IMD 0.089 (0.073 to 0.106) 4.9×10−24 0.084 (0.067 to 0.100) 7.3×10−22
Patient ethnicity (% white) 0.009 (−0.009 to 0.027) 0.32 −0.004 (−0.032 to 0.023) 0.78
Practice morbidity index (registrations/
1000 patients)
0.041 (0.024 to 0.059) 5.8×10−6 0.175 (−0.053 to 0.354) 0.12
Practice factors
GP supply (FTE/1000 patients) −0.014 (−0.033 to 0.004) 0.13 −0.016 (−0.026 to −0.005) 0.0046
Handedness of practice 0.001 (−0.002 to 0.003) 0.64 0.001 (−0.002 to 0.005) 0.44
GPs >50 years (%) −0.041 (−0.089 to 0.005) 0.082 −0.023 (−0.072 to 0.024) 0.35
GPs with non-UK qualifications (%) −0.007 (−0.029 to 0.014) 0.51 −0.035 (−0.058 to −0.012) 0.0025
Female GPs (%) 0.022 (−0.032 to 0.073) 0.42 0.049 (−0.024 to 0.117) 0.19
QOF indicator achievement (%)
Total QOF points −0.002 (−0.018 to 0.013) 0.78 −0.021 (−0.042 to 0.000) 0.045
PE07 0.041 (−0.012 to 0.092) 0.12 0.008 (−0.055 to 0.067) 0.80
PE08 0.062 (0.003 to 0.118) 0.04 0.031 (−0.039 to 0.096) 0.37
CHD06 −0.006 (−0.094 to 0.074) 0.88 −0.072 (−0.208 to 0.049) 0.26
CHD08 −0.033 (−0.171 to 0.088) 0.61 −0.135 (−0.317 to 0.021) 0.094
STROKE06 0.058 (−0.008 to 0.120) 0.086 0.076 (−0.008 to 0.153) 0.075
STROKE08 0.039 (−0.064 to 0.132) 0.44 0.031 (−0.088 to 0.137) 0.59
DM17 0.125 (−0.007 to 0.240) 0.063 0.128 (−0.023 to 0.257) 0.092
DM26 0.370 (0.222 to 0.490) 1.8×10−5 0.372 (0.218 to 0.496) 3.1×10−5
DM30 −0.031 (−0.120 to 0.050) 0.46 −0.144 (−0.280 to −0.022) 0.02
BP05 0.073 (−0.086 to 0.208) 0.35 0.138 (−0.069 to 0.304) 0.18
MED12 0.001 (−0.002 to 0.004) 0.55 0.000 (−0.003 to 0.003) 0.98
RECORD09 0.005 (0.000 to 0.009) 0.048 0.005 (−0.000 to 0.009) 0.053
Bold typeface denotes p<0.05.
Unadjusted and adjusted PAFs associated with each primary care factor are displayed. Each fraction refers to the difference between the
baseline scenario in table 1, and the sample scenario.
*Adjusted for practice, patient population age and sex.
†Adjusted for patient population age, sex, ethnicity, morbidity score and IMD, GP age, sex and country of qualification, and practice list size,
handedness and QOF achievement on the indicators listed.
FTE, full-time equivalent; GP, general practitioner; IMD, Index of Multiple Deprivation; PAF, population attributable fraction; QOF, Quality and
Outcomes Framework.
8 McKay AJ, et al. BMJ Open 2015;5:e008130. doi:10.1136/bmjopen-2015-008130
Open Access
group.bmj.com on January 11, 2016 - Published by http://bmjopen.bmj.com/Downloaded from 
speciﬁc concerns about blood pressure targets have led
the National Institute for Health and Care Excellence to
apply age-caps to hypertension treatment targets, where
evidence suggests treatment beneﬁt is limited to certain
age groups.54 Further investigation of the associations
identiﬁed using individual level data, which would allow
meaningful comparisons of effect size by age and ethni-
city, would help to demonstrate if there are particular
subgroups at risk of more harm than beneﬁt in the
pursuit of particular QOF targets. Consideration of
ADRs subsequent to only speciﬁc drugs or drug classes
would help to determine those implicated in the associa-
tions identiﬁed. Together, these pieces of information
would help inform prescribing guidance that minimises
potential prescribing-related harm.
CONCLUSIONS
ADR-related hospital episodes are associated with
various primary care factors, including achievement of
particular QOF indicators. Further investigation with
individual level data, and analysis of both, population
and ADR subgroups, would increase our understanding
of these associations. ADRs are candidates for PCSCs.
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